Unraveling the mystery surrounding post-acute sequelae of COVID-19
RK Ramakrishnan, T Kashour, Q Hamid… - Frontiers in …, 2021 - frontiersin.org
More than one year since its emergence, corona virus disease 2019 (COVID-19) is still
looming large with a paucity of treatment options. To add to this burden, a sizeable subset of …
looming large with a paucity of treatment options. To add to this burden, a sizeable subset of …
SARS-CoV-2 infection and COVID-19 vaccination in cancer patients undergoing immune checkpoint inhibitors
Y Yang, G Xu - Cell Death & Disease, 2023 - nature.com
Cancer patients are susceptible to severe acute respiratory syndrome coronavirus-2 (SARS-
CoV-2). Different antitumor treatments have attracted wide attention in the context of …
CoV-2). Different antitumor treatments have attracted wide attention in the context of …
Context-aware deconvolution of cell–cell communication with Tensor-cell2cell
Cell interactions determine phenotypes, and intercellular communication is shaped by
cellular contexts such as disease state, organismal life stage, and tissue microenvironment …
cellular contexts such as disease state, organismal life stage, and tissue microenvironment …
Long COVID-19 pathophysiology: what do we know so far?
NR Tziolos, P Ioannou, S Baliou, DP Kofteridis - Microorganisms, 2023 - mdpi.com
Long COVID-19 is a recognized entity that affects millions of people worldwide. Its broad
clinical symptoms include thrombotic events, brain fog, myocarditis, shortness of breath …
clinical symptoms include thrombotic events, brain fog, myocarditis, shortness of breath …
COVID-19 vaccines and thrombosis—roadblock or dead-end street?
Two adenovirus-based vaccines, ChAdOx1 nCoV-19 and Ad26. COV2. S, and two mRNA-
based vaccines, BNT162b2 and mRNA. 1273, have been approved by the European …
based vaccines, BNT162b2 and mRNA. 1273, have been approved by the European …
Myeloid-derived suppressor cells as a potential biomarker and therapeutic target in COVID-19
M Rowlands, F Segal, D Hartl - Frontiers in immunology, 2021 - frontiersin.org
Clinical presentations of COVID-19 are highly variable, yet the precise mechanisms that
govern the pathophysiology of different disease courses remain poorly defined. Across the …
govern the pathophysiology of different disease courses remain poorly defined. Across the …
[HTML][HTML] Role of myeloid-derived suppressor cells in viral respiratory infections; Hints for discovering therapeutic targets for COVID-19
The expansion of myeloid-derived suppressor cells (MDSCs), known as heterogeneous
population of immature myeloid cells, is enhanced during several pathological conditions …
population of immature myeloid cells, is enhanced during several pathological conditions …
Longitudinal immune dynamics of mild COVID-19 define signatures of recovery and persistence
SARS-CoV-2 has infected over 160 million and caused more than 3 million deaths to date.
Most individuals (> 80%) have mild symptoms and recover in the outpatient setting, but …
Most individuals (> 80%) have mild symptoms and recover in the outpatient setting, but …
Inhibitory immune checkpoint receptors and ligands as prognostic biomarkers in COVID-19 patients
Coronavirus disease 2019 (COVID-19) is caused by SARS-CoV-2. During T-cell activation,
the immune system uses different checkpoint pathways to maintain co-inhibitory and co …
the immune system uses different checkpoint pathways to maintain co-inhibitory and co …
[HTML][HTML] Inhibitory immune checkpoint molecules and exhaustion of T cells in COVID-19
M Barnova, A Bobcakova, V Urdova… - Physiological …, 2021 - ncbi.nlm.nih.gov
Summary COVID-19 (Coronavirus Disease) is an infectious disease caused by the
coronavirus SARS-CoV-2 (Severe acute respiratory syndrome Coronavirus 2), which …
coronavirus SARS-CoV-2 (Severe acute respiratory syndrome Coronavirus 2), which …